BRAF and KRAS mutations in metastatic colorectal cancer: future perspectives for personalized therapy

Colorectal cancer (CRC) is one of the most commonly diagnosed cancers worldwide and 30% of patients with CRC experience metastasis. Patients with metastatic colorectal cancer (mCRC) have a 5-year overall survival rate of <10%. V-raf murine sarcoma viral oncogene homolog B1 (BRAF) and V-Ki-ras2 Ki...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zi-Nan, Zhao, Lin, Yu, Li-Feng, Wei, Min-Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333923/
https://www.ncbi.nlm.nih.gov/pubmed/32665851
http://dx.doi.org/10.1093/gastro/goaa022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333923/
https://www.ncbi.nlm.nih.gov/pubmed/32665851
http://dx.doi.org/10.1093/gastro/goaa022

Ejemplares similares